Database : HANSEN Search on : PREDNISONA [Subject descriptor] References found : 11 [refine] Displaying: 1 .. 11   in format [Detailed]

page 1 de 1

1 / 11

HANSEN

select to print

Id: 17683 Author: Minas Gerais (Estado). Secretaria do Estado de Saude. Coordenadoria Estadual de Dermatologia Sanitaria de Minas Gerais. Title: Como tratar reaçoes hansenicas / ? Source: In: Minas Gerais (Estado). Secretaria do Estado de Saude. Coordenadoria Estadual de Dermatologia Sanitaria de Minas Gerais.Como reconhecer e tratar reações hansenicas. Belo Horizonte, Ilep, 2005. p.36-53tab. Descriptors: HANSENIASE/imunol HANSENIASE/prev HANSENIASE/reabil PREDNISONA/anal PREDNISONA/sint quim PREDNISONA/uso terap QUIMIOTERAPIA COMBINADA Limits: RELATO DE CASO ESTUDO COMPARATIVO HUMANO Location: BR191.1; . 66lc

2 / 11

HANSEN

select to print

Id: 13937 Author: Teles, Rosane M. B; Moraes, Milton O; Geraldo, Natasha T. R; Salles, Ana M; Sarno, Euzenir N; Sampaio, Elizabeth P Title: Differential TNFalpha mRNA regulation detected in the epidermis of leprosy patients ..- Source: s.l; s.n; 2002. 8 p. ilus, tab, graf. Abstract: The epidermis is an important site of the immunoinflammatory response in the skin. In the present study, the expression of cytokine and ICAM-1 (intercellular adhesion molecule-1) genes was evaluated by RT-PCR in the epidermis isolated from biopsies from 25 reactional leprosy patients. TNFalpha and IL-6 mRNAs were detected in all individuals during the reactional state (reversal reaction or erythema nodosum leprosum), IL-8 message was detected in 66.6 per cent and 62.5 per cent of the patients, IL-12 mRNA was present in 91.6 per cent and 62.5 per cent and ICAM-1 in 100 per cent and 71.4 per cent, respectively. In addition, when skin biopsies were obtained from the same patients before and during the reactional episode, an enhancement in cytokine mRNA, but not in ICAM-1 mRNA, was observed. Seven patients were also evaluated at the onset of reaction and during antiinflammatory treatment. In contrast to a preferential decrease in the TNFalpha gene detected in the dermis, during the treatment phase, persistent/enhanced TNFalpha mRNA expression was detected in the epidermis in six out of the seven patients assessed. This peculiar pattern of expression might reflect a differential impact that in vivo antiinflammatory therapy has on the epidermis. The present findings indicate that the epidermis plays an important role in the local inflammatory response in leprosy and that the profile of response detected in the epidermis during the reactions may be regulated differently from that in the dermis. (AU). Descriptors: CITOCINAS/genet CITOCINAS/metab ANTIINFLAMATORIOS ESTERÓIDES/uso terap DERME/metab HANSENOSTATICOS/uso terap EPIDERME/metab MOLECULA 1 DE ADESAO INTERCELULAR/genet MOLECULA 1 DE ADESAO INTERCELULAR/metab HANSENIASE/quimioter HANSENIASE/metab PENTOXIFILINA/uso terap ANTIINFLAMATORIOS/uso terap RNA MENSAGEIRO/metab TALIDOMIDA/uso terap PREDNISONA/uso terap FATOR DE NECROSE TUMORAL/genet FATOR DE NECROSE TUMORAL/metab Limits: HUMANO MASCULINO FEMININO ADULTO MEIA-IDADE IDOSO SUPPORT, NON-U.S. GOV'T Electronic Medium: http://www.ilsl.br Location: BR191.1; 09157/s

3 / 11

HANSEN

select to print

Id: 13522 Author: Taborda, Paulo Rogério Oldani; Taborda, Valeria Brega Alvares Title: Granulomatose de Wegener Wegener's granulomatosis- Source: s.l; s.n; 1998. 7 p. ilus, tab. Abstract: A granulomatose de Wegener (GW) é considerada vasculite sistêmica granulomatosa necrotizante de vasos de pequeno e médio calibres, idiopática, com envolvimento multissistêmico, geralmente afetando trato respiratório e rins. Pode ser dividida em duas formas: clássica e limitada. Nesta última inexiste comprometimento renal. Os pacientes habitualmente apresentam febre, artralgias, nódulos esparsos na pele, ulceraçäo mucosa e tosse improdutiva. Os sintomas pulmonares podem variar desde sinusites até hemorragia pulmonar difusa e insuficiência respiratória. O envolvimento renal é comumente expresso pela insuficiência renal crônica (IRC). Dados laboratoriais inespecíficos refletem alteraçöes urinárias e anemia, pela IRC, e atividade inflamatória aguda. Em contraposiçäo, considera-se o ANCA o mais específico no diagnóstico. A radiografia de tórax pode mostrar infiltrados, nódulos ou cavitaçöes pulmonares. Nas biópsias observam-se vasculite neutrofílica ou granulomatosa necrotizante, com células gigantes nos granulomas epitelióides. O tratamento com corticosteróides e imunossupressores melhorou significativamente o prognóstico da doença. Uma revisäo da clínica, da histopatologia e dos achados laboratoriais da GW é apresentada, e, particularmente, as manifestaçöes cutâneas, pulmonares e renais säo discutidas. (AU). Descriptors: COMBINACAO TRIMETOPRIM-SULFAMETOXAZOL/uso terap PNEUMOPATIAS/etiol VASCULITE GRANULOMATOSE DE WEGENER ANTIBIOTICOS ANTINEOPLASICOS PREDNISONA/uso terap CICLOFOSFAMIDA/ef adv CICLOFOSFAMIDA/uso terap INSUFICIÊNCIA RENAL CRÔNICA/etiol Limits: HUMANO Location: BR191.1; 04413/s

4 / 11

HANSEN

select to print

Id: 13510 Author: Qunibi, Wajeh Y; Godwin, John; Eknoyan, Garabed Title: Toxic nephropathy during continuous rifampin therapy ..- Source: s.l; s.n; jun. 1980. 2 p. tab. Abstract: A relatively mild nonoliguric acute renal failure developed early in the course of daily rifampin treatment in a 54-year-old man who was receiving concomitant steroid therapy. The renal lesion was an acute interstitial nephritis characterized by tubular dysfunction:inability to concentrate urine, increase in fractional excretion of sodium and uric acid, and glycosuria with normal blood glucose values. All abnormalities resolved promptly upon withdrawal of rifampin while steroid therapy was gradually reduced. The documents the fact that rifampin-induced nephropathy can occur in the course of a continuous daily regimen and may be favorably influenced by steroid administration.(AU). Descriptors: QUIMIOTERAPIA COMBINADA INSUFICIÊNCIA RENAL AGUDA/ind quim PREDNISONA/admin PREDNISONA/uso terap RIFAMPINA/admin RIFAMPINA/ef adv FATORES DE TEMPO TUBERCULOSE PULMONAR/quimioter Limits: RELATO DE CASO HUMANO MASCULINO MEIA-IDADE Electronic Medium: http://www.ilsl.br Location: BR191.1; 00442/s

5 / 11

HANSEN

select to print

Id: 12254 Author: Bourée, P; Brette, A. de; Carsalade, G. Y. de Title: Réaction lépreuse tardive apparue 18 mois après la fin d'un traitement Late reversal leprous reaction appearing 18 months after the termination of treatment- Source: s.l; s.n; mars 2001. 1 p. . Descriptors: ANTIINFLAMATORIOS NAO ESTEROIDES ANTIINFLAMATORIOS NAO ESTEROIDES ANTIINFLAMATORIOS ESTEROIDES ANTIINFLAMATORIOS ESTEROIDES BIOPSIA CLOFAZIMINA CLOFAZIMINA TINTURAS SEGUIMENTOS HIPERSENSIBILIDADE TARDIA LEPROSTATICOS LEPROSTATICOS LEPROSTATICOS HANSENIASE DIMORFA HANSENIASE DIMORFA HANSENIASE DIMORFA MYCOBACTERIUM LEPRAE MYCOBACTERIUM LEPRAE PREDNISONA PREDNISONA PELE FATORES DE TEMPO Limits: RELATO DE CASO Location: BR191.1; 08684/s

6 / 11

HANSEN

select to print

Id: 11935 Author: Cohen, Jack B Title: Cutaneous involvement of dermatomyositis can respond to dapsone therapy ..- Source: s.l; s.n; 2002. 3 p. . Descriptors: DERMATOMIOSITE DERMATOMIOSITE ANTIINFECCIOSOS DAPSONA DIAGNOSTICO DIFERENCIAL HIDROXICLOROQUINA IMUNOSSUPRESSORES PREDNISONA QUINACRINA Location: BR191.1; 08596/s

7 / 11

HANSEN

select to print

Id: 11719 Author: Samant, Rohini; Nadkar, M. Y; Vaidya, S. S; Chhugani, S. J; Balaji, R; Borges, N. E Title: Leprosy: a close mimic in a rheumatology clinic ..- Source: s.l; s.n; jun. 1999. 4 p. . Descriptors: HANSENIASE HANSENIASE BIOPSIA DAPSONA DIAGNOSTICO DIFERENCIAL PREDNISONA DOENÇAS REUMATICAS REUMATOLOGIA PELE Location: BR191.1; 07487/s

8 / 11

HANSEN

select to print

Id: 11643 Author: Cohen, Jack B Title: Cutaneous involvement of dermatomyositis can respond to dapsone therapy ..- Source: s.l; s.n; 2002. 3 p. . Descriptors: DERMATOMIOSITE DERMATOMIOSITE ANTIINFECCIOSOS DAPSONA DIAGNOSTICO DIFERENCIAL HIDROXICLOROQUINA IMUNOSSUPRESSORES PREDNISONA QUINACRINA Location: BR191.1; 08504/s

9 / 11

HANSEN

select to print

Id: 11439 Author: Bourée, P; Brette, A. de; Carsalade, G. Y. de Title: Réaction lépreuse tardive apparue 18 mois après la fin d'un traitement Late reveral leprous reaction appearing 18 months after the termination of treatment- Source: s.l; s.n; 2001. 1 p. . Descriptors: ANTIINFLAMATORIOS NAO ESTEROIDES ANTIINFLAMATORIOS NAO ESTEROIDES ANTIINFLAMATORIOS ESTEROIDES ANTIINFLAMATORIOS ESTEROIDES BIOPSIA CLOFAZIMINA CLOFAZIMINA TINTURAS SEGUIMENTOS HIPERSENSIBILIDADE TARDIA LEPROSTATICOS LEPROSTATICOS LEPROSTATICOS HANSENIASE DIMORFA HANSENIASE DIMORFA HANSENIASE DIMORFA MYCOBACTERIUM LEPRAE MYCOBACTERIUM LEPRAE PREDNISONA PREDNISONA PELE FATORES DE TEMPO Limits: RELATO DE CASO Location: BR191.1; 08321/s

10 / 11

HANSEN

select to print

Id: 9535 Author: Maman Junior, Italo; Baldi, Alexandre Busetti; Campos, Luis Carlos Title: Hanseniase Leprosy- Source: Porto Alegre; s.n; 1994. 14 p. tab. Descriptors: SULFONAS RIFAMPINA CLOFAZIMINA TALIDOMIDA PREDNISONA HANSENIASE HANSENIASE HANSENIASE QUIMIOTERAPIA COMBINADA DIAGNOSTICO DIFERENCIAL ANTIGENO DE MITSUDA PROGNOSTICO Location: BR191.1; 06261/s

11 / 11

HANSEN

select to print

Id: 9184 Author: Drateln, Claudia Reynoso von Title: Sarcoma de Kaposi en un paciente con lepra lepromatosa VIH negativo ?- Source: s.l; s.n; 1994. 3 p. ilus. Descriptors: SARCOMA DE KAPOSI NEOPLASIAS CUTANEAS HANSENIASE LEPROMATOSA PREDNISONA AMILOIDOSE AMILOIDOSE DAPSONA CLOFAZIMINA Location: BR191.1; 06152/s

---

page 1 de 1

Refine the search

Database : HANSEN

Advanced form

Search for : Free form

		Search	in field
1			WordsTitle wordsAbstract wordsAuthorInstitutional authorSubject descriptorLimitsLanguageCountry, year publicationJournalType of literatureBibliographic levelMonography in seriesPublication typeConferenceUnique identifierLocationElectronic supportEntry dateRecord type
2	and or and not		WordsTitle wordsAbstract wordsAuthorInstitutional authorSubject descriptorLimitsLanguageCountry, year publicationJournalType of literatureBibliographic levelMonography in seriesPublication typeConferenceUnique identifierLocationElectronic supportEntry dateRecord type
3	and or and not		WordsTitle wordsAbstract wordsAuthorInstitutional authorSubject descriptorLimitsLanguageCountry, year publicationJournalType of literatureBibliographic levelMonography in seriesPublication typeConferenceUnique identifierLocationElectronic supportEntry dateRecord type

Search engine: iAH powered by WWWISIS

IAH - © BIREME/PAHO/WHO Latin American and Caribbean Center on Health Sciences Information